![Martin Jensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Jensen
Gründer bei
EXPRES2ION BIOTECH HOLDING AB
Profil
Martin Roland Jensen is the founder.
Dr. Jensen is the founder of ExpreS2ion Biotechnologies ApS, founded in 2009, holding the title of Chairman.
Dr. Jensen is the founder of Expres2ion Biotech Holding AB, founded in 2010, holding the title of Chairman.
Dr. Jensen is also the founder of Unikum Therapeutics ApS,Medic Advice ApS,Martin Roland Holding ApS.
Dr. Jensen is currently the Chief Business Officer at Cell2Cure ApS.
Former positions include Chief Executive Officer at CytoVac AS, Principal at Pharmexa A, Principal at T-cellic A, and Principal at Scancell A. Education includes a graduate degree and a doctorate from the University of Copenhagen, both conferred in 1994.
Aktive Positionen von Martin Jensen
| Unternehmen | Position | Beginn |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Gründer | 01.01.2010 |
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Gründer | 01.01.2009 |
Martin Roland Holding ApS | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Martin Jensen
| Unternehmen | Position | Ende |
|---|---|---|
Medic Advice ApS | Vorstandsvorsitzender | 29.05.2014 |
Unikum Therapeutics ApS
 Unikum Therapeutics ApS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of natural sciences & engineering | Gründer | - |
CytoVac AS
 CytoVac AS BiotechnologyHealth Technology Manufactures pharmaceuticals | Vorstandsvorsitzender | - |
Scancell A/S | Corporate Officer/Principal | - |
T-cellic A/S | Corporate Officer/Principal | - |
Ausbildung von Martin Jensen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
99
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
T-cellic A/S | |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Health Technology |
CytoVac AS
CytoVac AS BiotechnologyHealth Technology Manufactures pharmaceuticals | Health Technology |
Scancell A/S | |
Expres2ion Biotech Holding AB
 Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
Medic Advice ApS | |
Martin Roland Holding ApS | |
Unikum Therapeutics ApS
Unikum Therapeutics ApS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of natural sciences & engineering | Commercial Services |
